Next-generation sequencing hardware and surface chemistry platform
Element Biosciences develops sequencing instruments and assay chemistries for life science research. The stack reveals a hardware-first company: FPGA, GPU, embedded Linux, and C/C++ dominate the technical footprint, paired with SolidWorks for design and MATLAB for simulation. Active hiring skews heavily toward engineering (9 roles) and research (5), with senior-level dominance (15 of 24 open positions), indicating rapid scaling of technical depth rather than breadth — a pattern common when moving lab-proven chemistries into manufacturing at scale.
Element Biosciences is a San Diego-based life science instrumentation company founded in 2017, operating in the 201–500 employee range. The business centers on developing next-generation DNA sequencing systems and the underlying surface chemistry that powers them. Internal projects reflect the dual engineering challenge: novel surface chemistry research alongside manufacturing transfer, process development, and flow cell optimization. The company is also executing sales and marketing infrastructure (beta programs, paid media, organizational structure work), indicating a transition from R&D-led to commercialization-led operations. Hiring spans five countries, with concentration in the U.S., Europe, and Asia-Pacific.
Element's stack includes FPGA, GPU, embedded Linux, C/C++, Python, Docker, and MATLAB. The company also uses SolidWorks for hardware design and ISO 13485 / IEC 62304 compliance frameworks, reflecting medical-device-grade engineering rigor.
San Diego, California. The company also hires across Singapore, United States, Netherlands, France, and Japan.
Other companies in the same industry, closest in size